TY - JOUR
T1 - Clinical implications of statin event trials.
AU - Goldberg, Anne Carol
PY - 2002/9
Y1 - 2002/9
N2 - Event trials using statin therapy have shown a beneficial effect on rates of cardiovascular events. The three statins that have been used in long-term trials have shown generally similar effects on rates of myocardial infarction, stroke, revascularizations, and mortality. Safety data appear to be comparable for lovastatin, pravastatin, and simvastatin. Long-term trials of other statins are in progress or pending. The question of how much low-density lipoprotein cholesterol should be lowered may be answered by studies currently in progress.
AB - Event trials using statin therapy have shown a beneficial effect on rates of cardiovascular events. The three statins that have been used in long-term trials have shown generally similar effects on rates of myocardial infarction, stroke, revascularizations, and mortality. Safety data appear to be comparable for lovastatin, pravastatin, and simvastatin. Long-term trials of other statins are in progress or pending. The question of how much low-density lipoprotein cholesterol should be lowered may be answered by studies currently in progress.
UR - https://www.scopus.com/pages/publications/0347310960
U2 - 10.1007/s11883-002-0070-y
DO - 10.1007/s11883-002-0070-y
M3 - Article
C2 - 12162932
AN - SCOPUS:0347310960
SN - 1523-3804
VL - 4
SP - 337
EP - 342
JO - Current Atherosclerosis Reports
JF - Current Atherosclerosis Reports
IS - 5
ER -